Skip to main content
Erschienen in: Rheumatology International 11/2014

01.11.2014 | Original Article

Genital aphthosis in Behçet’s disease: Is it associated with less eye involvement?

verfasst von: Seyedeh Tahereh Faezi, Cheyda Chams-Davatchi, S. Zahra Ghodsi, Farhad Shahram, Abdolhadi Nadji, Massoomeh Akhlaghi, Kamran Moradi, Pedram Paragomi, Golnaz Ghazizadeh Esslami, Bahar Sadeghi Abdollahi, Farimah Ashofteh, Fereydoun Davatchi

Erschienen in: Rheumatology International | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Behçet’s disease (BD) is a multisystem disease classified among the vasculitides with various clinical features. Genital aphthosis (GA) is one of the major manifestations of BD. The aim of this study was to evaluate the characteristics of BD patients with GA. A cross-sectional sample of BD patients registered in 37 years was selected. We determined clinical and laboratory features of BD patients with GA (GA cases) and compared them with the patients who never developed GA (non-GA cases). The comparisons were performed by the chi-square test and logistic regression analysis. Odds ratios (ORs) with 95 % confidence intervals were calculated to estimate the precision of ORs. Among 6,935 BD patients, 4,489 cases (64.7 %) were ascribed to GA cases. Male to female ratio (1.11:1.00 vs. 1.48:1.00 OR 0.753, P value <0.001) and mean age of disease onset (OR = 0.9, P value <0.001) were lower in GA subset. In GA cases, oral aphthosis (OA) was a more common onset manifestation (OR 2.250, P value <0.001), while uveitis (OR 0.140, P value <0.001) and retinal vasculitis (OR 0.077, P value <0.001) were less common at the disease onset. In the whole course of disease, eye involvement was less common in GA cases (OR 0.215, P value <0.001). On the contrary, OA (OR 19.698, P value <0.001), skin (OR 1.762, P value <0.001), joint (OR 1.257, P value = 0.001), gastrointestinal (OR 1.302, P value = 0.009), neurological (OR 1.624, P value <0.001) and vascular involvements (OR 1.362, P value <0.001), epididymitis (OR 1.596, P value <0.001), positive pathergy test (OR 1.209, P value <0.001) and positive familial history of OA (OR 1.325, P value <0.001) were more common in GA subset. This study showed that GA subset of BD is associated with less eye involvement but higher rates of other BD manifestations.
Literatur
3.
Zurück zum Zitat Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Abdollahi BS (2010) Behcet’s disease: from east to west. Clin Rheumatol 29(8):823–833. doi:10.1007/s10067-010-1430-6 PubMedCrossRef Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Abdollahi BS (2010) Behcet’s disease: from east to west. Clin Rheumatol 29(8):823–833. doi:10.​1007/​s10067-010-1430-6 PubMedCrossRef
4.
Zurück zum Zitat Fei Y, Li X, Lin S, Song X, Wu Q, Zhu Y, Gao X, Zhang W, Zhao Y, Zeng X, Zhang F (2013) Major vascular involvement in Behcet’s disease: a retrospective study of 796 patients. Clin Rheumatol 32(6):845–852. doi:10.1007/s10067-013-2205-7 PubMedCrossRef Fei Y, Li X, Lin S, Song X, Wu Q, Zhu Y, Gao X, Zhang W, Zhao Y, Zeng X, Zhang F (2013) Major vascular involvement in Behcet’s disease: a retrospective study of 796 patients. Clin Rheumatol 32(6):845–852. doi:10.​1007/​s10067-013-2205-7 PubMedCrossRef
5.
Zurück zum Zitat al-Dalaan AN, al Balaa SR, el Ramahi K, al-Kawi Z, Bohlega S, Bahabri S, al Janadi MA (1994) Behcet’s disease in Saudi Arabia. J Rheumatol 21(4):658–661PubMed al-Dalaan AN, al Balaa SR, el Ramahi K, al-Kawi Z, Bohlega S, Bahabri S, al Janadi MA (1994) Behcet’s disease in Saudi Arabia. J Rheumatol 21(4):658–661PubMed
6.
Zurück zum Zitat Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC (2006) Epidemiologie und Klinik des Morbus Adamantiades‐Behçet in Deutschland–Aktuelle pathogenetische Konzepte und therapeutische Möglichkeiten. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 4 (1) Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC (2006) Epidemiologie und Klinik des Morbus Adamantiades‐Behçet in Deutschland–Aktuelle pathogenetische Konzepte und therapeutische Möglichkeiten. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 4 (1)
7.
Zurück zum Zitat Bang D, Lee JH, Lee ES, Lee S, Choi JS, Kim YK, Cho BK, Koh JK, Won YH, Kim NI, Park SD, Ahn HJ, Lee YW, Wang HY, Lee WW, Eun HC, Song ES, Lee SW, Lee CW, Lee CJ, Park JH, Song YW, Kim ST, Kim CY, Park JK, Kwon KS (2001) Epidemiologic and clinical survey of Behcet’s disease in Korea: the first multicenter study. J Korean Med Sci 16(5):615–618 Bang D, Lee JH, Lee ES, Lee S, Choi JS, Kim YK, Cho BK, Koh JK, Won YH, Kim NI, Park SD, Ahn HJ, Lee YW, Wang HY, Lee WW, Eun HC, Song ES, Lee SW, Lee CW, Lee CJ, Park JH, Song YW, Kim ST, Kim CY, Park JK, Kwon KS (2001) Epidemiologic and clinical survey of Behcet’s disease in Korea: the first multicenter study. J Korean Med Sci 16(5):615–618
8.
Zurück zum Zitat Berrah A, Remache A, Ouadahi N, Ayoub S, Hakem D, Boudjelida H, Bensalah D, Kessal F, Zemmour D (2000) Clinical manifestations of Behcet’s disease. Analysis of 58 cases. Yonsei Med J 41:P 006 Berrah A, Remache A, Ouadahi N, Ayoub S, Hakem D, Boudjelida H, Bensalah D, Kessal F, Zemmour D (2000) Clinical manifestations of Behcet’s disease. Analysis of 58 cases. Yonsei Med J 41:P 006
9.
Zurück zum Zitat Davatchi F, Shahram F, Akbarian M, Gharibdoost F, Chams C, Champs H, Nadji A (1993) Classification tree for diagnosis of Behcet’s disease. Expert Medica 245–248 Davatchi F, Shahram F, Akbarian M, Gharibdoost F, Chams C, Champs H, Nadji A (1993) Classification tree for diagnosis of Behcet’s disease. Expert Medica 245–248
11.
Zurück zum Zitat Pande I, Uppal SS, Kailash S, Kumar A, Malaviya AN (1995) Behcet’s disease in India: a clinical, immunological, immunogenetic and outcome study. Br J Rheumatol 34(9):825–830PubMedCrossRef Pande I, Uppal SS, Kailash S, Kumar A, Malaviya AN (1995) Behcet’s disease in India: a clinical, immunological, immunogenetic and outcome study. Br J Rheumatol 34(9):825–830PubMedCrossRef
13.
Zurück zum Zitat Sharquie K, Al-Araji A, Al-Rawi Z, Al-Yaqubi O, Hatem A (2000) Behcet’s Disease in Iraqi patients. A prospective study from a newly established multidiscipline clinic. Mecca Publishing, Seoul Sharquie K, Al-Araji A, Al-Rawi Z, Al-Yaqubi O, Hatem A (2000) Behcet’s Disease in Iraqi patients. A prospective study from a newly established multidiscipline clinic. Mecca Publishing, Seoul
14.
Zurück zum Zitat Sungur G, Hazirolan D, Hekimoglu E, Kasim R, Duman S (2010) Late-onset Behcet’s disease: demographic, clinical, and ocular features. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 248(9):1325–1330. doi:10.1007/s00417-010-1399-5 CrossRef Sungur G, Hazirolan D, Hekimoglu E, Kasim R, Duman S (2010) Late-onset Behcet’s disease: demographic, clinical, and ocular features. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 248(9):1325–1330. doi:10.​1007/​s00417-010-1399-5 CrossRef
15.
Zurück zum Zitat Tursen U, Gurler A, Boyvat A (2003) Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet’s disease. Int J Dermatol 42(5):346–351PubMedCrossRef Tursen U, Gurler A, Boyvat A (2003) Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet’s disease. Int J Dermatol 42(5):346–351PubMedCrossRef
17.
Zurück zum Zitat Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, Keitel W, Stadler R, Wollina U, Proksch E, Sohnchen R, Weber H, Gollnick HP, Holzle E, Fritz K, Licht T, Orfanos CE (1997) Epidemiological features of Adamantiades–Behcet’s disease in Germany and in Europe. Yonsei Med J 38(6):411–422PubMedCrossRef Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, Keitel W, Stadler R, Wollina U, Proksch E, Sohnchen R, Weber H, Gollnick HP, Holzle E, Fritz K, Licht T, Orfanos CE (1997) Epidemiological features of Adamantiades–Behcet’s disease in Germany and in Europe. Yonsei Med J 38(6):411–422PubMedCrossRef
22.
Zurück zum Zitat Alpsoy E (2005) Behcet’s disease: treatment of mucocutaneous lesions. Clin Exp Rheumatol 23(4):532–539PubMed Alpsoy E (2005) Behcet’s disease: treatment of mucocutaneous lesions. Clin Exp Rheumatol 23(4):532–539PubMed
23.
Zurück zum Zitat Faezi ST, Paragomi P, Shahram F, Shams H, Shams-Davatchi C, Ghodsi Z, Nadji A, Akhlaghi M, Davatchi F (2013) Clinical features of Behcet’s disease in patients without oral aphthosis. Mod Rheumatol/Japan Rheum Assoc. doi:10.3109/14397595.2013.844400 Faezi ST, Paragomi P, Shahram F, Shams H, Shams-Davatchi C, Ghodsi Z, Nadji A, Akhlaghi M, Davatchi F (2013) Clinical features of Behcet’s disease in patients without oral aphthosis. Mod Rheumatol/Japan Rheum Assoc. doi:10.​3109/​14397595.​2013.​844400
24.
Zurück zum Zitat Shahram F, Assadi K, Davatchi F, Nadji A, Jamshidi A, Chams C, Akbarian M (2003) Chronology of clinical manifestations in Behçet’s disease. Adamantiades–Behçet’s disease. Springer, New York, pp 85–89 Shahram F, Assadi K, Davatchi F, Nadji A, Jamshidi A, Chams C, Akbarian M (2003) Chronology of clinical manifestations in Behçet’s disease. Adamantiades–Behçet’s disease. Springer, New York, pp 85–89
25.
Zurück zum Zitat Davatchi F, Shahram F, Akbarian M, Gharibdoost F, Chams C, Chams H, Mansoori P, Nadji A (1993) Classification tree for the diagnosis of Behcet’s disease. Revue de Medecine Interne 14:076 Davatchi F, Shahram F, Akbarian M, Gharibdoost F, Chams C, Chams H, Mansoori P, Nadji A (1993) Classification tree for the diagnosis of Behcet’s disease. Revue de Medecine Interne 14:076
26.
Zurück zum Zitat International Team for the Revision of International Criteria for Behçet’s Disease: Clinical manifestations of Behçet’s disease. The ITR-ICBD report. In, 2008 2008. vol Suppl 50. Clin Exp Rheumatol p S1-18 International Team for the Revision of International Criteria for Behçet’s Disease: Clinical manifestations of Behçet’s disease. The ITR-ICBD report. In, 2008 2008. vol Suppl 50. Clin Exp Rheumatol p S1-18
27.
Zurück zum Zitat Alpsoy E, Donmez L, Bacanli A, Apaydin C, Butun B (2003) Review of the chronology of clinical manifestations in 60 patients with Behcet’s disease. Dermatology 207(4):354–356. doi:10.1159/000074113 Alpsoy E, Donmez L, Bacanli A, Apaydin C, Butun B (2003) Review of the chronology of clinical manifestations in 60 patients with Behcet’s disease. Dermatology 207(4):354–356. doi:10.​1159/​000074113
29.
Zurück zum Zitat Dilsen N, Konice M, Aral O (1986) Our diagnostic criteria for Behcet’s disease: an overview. Paper presented at the Royal Society of Medicine Services, International Congress and Symposium Series 103, London Dilsen N, Konice M, Aral O (1986) Our diagnostic criteria for Behcet’s disease: an overview. Paper presented at the Royal Society of Medicine Services, International Congress and Symposium Series 103, London
30.
Zurück zum Zitat O’Neill TW, Rigby AS, Silman AJ, Barnes C (1994) Validation of the International Study Group criteria for Behcet’s disease. Br J Rheumatol 33(2):115–117PubMedCrossRef O’Neill TW, Rigby AS, Silman AJ, Barnes C (1994) Validation of the International Study Group criteria for Behcet’s disease. Br J Rheumatol 33(2):115–117PubMedCrossRef
32.
Zurück zum Zitat Chams-Davatchi C, Davatchi F, Nadji A, Shahram F, Chams H, Jamshidi A (2004) Genital aphthosis and Behcet’s disease (BD). Paper presented at the International Conference on Behcet’s Disease, Antalya, Turkey, 27–31 October 2004 Chams-Davatchi C, Davatchi F, Nadji A, Shahram F, Chams H, Jamshidi A (2004) Genital aphthosis and Behcet’s disease (BD). Paper presented at the International Conference on Behcet’s Disease, Antalya, Turkey, 27–31 October 2004
33.
Zurück zum Zitat Zouboulis CC (1999) Epidemiology of Adamantiades–Behcet’s disease. Ann Med Interne (Paris) 150(6):488–498 Zouboulis CC (1999) Epidemiology of Adamantiades–Behcet’s disease. Ann Med Interne (Paris) 150(6):488–498
34.
Zurück zum Zitat Cho S, Kim J, Cho SB, Zheng Z, Choi MJ, Kim DY, Bang D (2012) Immunopathogenic characterization of cutaneous inflammation in Behcet’s disease. J Eur Acad Dermatol Venereol: JEADV. doi:10.1111/jdv.12054 Cho S, Kim J, Cho SB, Zheng Z, Choi MJ, Kim DY, Bang D (2012) Immunopathogenic characterization of cutaneous inflammation in Behcet’s disease. J Eur Acad Dermatol Venereol: JEADV. doi:10.​1111/​jdv.​12054
35.
36.
Zurück zum Zitat Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H (2004) Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet’s disease. Arthritis Rheum 50(7):2291–2295. doi:10.1002/art.20334 PubMedCrossRef Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H (2004) Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet’s disease. Arthritis Rheum 50(7):2291–2295. doi:10.​1002/​art.​20334 PubMedCrossRef
38.
Zurück zum Zitat Sakamoto M, Akazawa K, Nishioka Y, Sanui H, Inomata H, Nose Y (1995) Prognostic factors of vision in patients with Behcet disease. Ophthalmology 102(2):317–321PubMedCrossRef Sakamoto M, Akazawa K, Nishioka Y, Sanui H, Inomata H, Nose Y (1995) Prognostic factors of vision in patients with Behcet disease. Ophthalmology 102(2):317–321PubMedCrossRef
39.
Zurück zum Zitat Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S, Usta A, Kandi B, Durusoy C, Seyhan M, Utas S, Saricaoglu H, Ozden MG, Uzun S, Tursen U, Cicek D, Donmez L, Alpsoy E (2008) Demographic and clinical properties of juvenile-onset Behcet’s disease: a controlled multicenter study. J Am Acad Dermatol 58(4):579–584. doi:10.1016/j.jaad.2007.10.452 PubMedCrossRef Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S, Usta A, Kandi B, Durusoy C, Seyhan M, Utas S, Saricaoglu H, Ozden MG, Uzun S, Tursen U, Cicek D, Donmez L, Alpsoy E (2008) Demographic and clinical properties of juvenile-onset Behcet’s disease: a controlled multicenter study. J Am Acad Dermatol 58(4):579–584. doi:10.​1016/​j.​jaad.​2007.​10.​452 PubMedCrossRef
Metadaten
Titel
Genital aphthosis in Behçet’s disease: Is it associated with less eye involvement?
verfasst von
Seyedeh Tahereh Faezi
Cheyda Chams-Davatchi
S. Zahra Ghodsi
Farhad Shahram
Abdolhadi Nadji
Massoomeh Akhlaghi
Kamran Moradi
Pedram Paragomi
Golnaz Ghazizadeh Esslami
Bahar Sadeghi Abdollahi
Farimah Ashofteh
Fereydoun Davatchi
Publikationsdatum
01.11.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 11/2014
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3011-5

Weitere Artikel der Ausgabe 11/2014

Rheumatology International 11/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.